FindTrial
Sign In

High flow nasal oxygenation as assiteds device for intubation in COVID Patients

Role of high flow nasal oxygenation during video Laryngoscopy assisted intubation in COVID-positive patients: A randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034167
Enrollment
30
Registered
2021-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: HFNC: APPLYING HFNC FOR PREOXYGENATION Control Intervention1: STANDARD MASK OXYGENATION: STANDARD MASK OXYGENATION AS PREOXYGENATION

Sponsors

Institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients requiring intubation in ICU 2. Sex M/F 3. Age: 18years or older 4. Weight: 40-100 kg

Exclusion criteria

Exclusion criteria: 1. Intubation without RSI(in case of cardiac arrest) 2. Asphyxia requiring immediate intubation 3. Any nasopharyngeal anatomical obstacle 4. Grade 4 glottis exposure on the Cormackâ??Lehane scale documented in the medical history 5. pregnancy 6. Lack of consent 7. patients who had already undergone intubation in the ICU (i.e., extubation failure) or who were already participating in an interventional study on pre-oxygenation

Design outcomes

Primary

MeasureTime frame
median lowest sp02 during intubationTimepoint: baseline, 1 Mins, 2 Mins—

Secondary

MeasureTime frame
SpO2 from the beginning of pre-oxygenation to the end of intubationTimepoint: Baseline, 2 Mins—

Countries

India

Contacts

Public Contactdr rajesh kumar meena

Institute Of Medical Sciences

drrajaiims86@gmail.com9643975465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026